Trending...
- 13 Full Moons of Black Dandelion Convergent Voice™ An Integration of Literacy & Wellness Symposium
- Notice: Hrm Queen Laurence I Assumes Crown Control & $317q Fund. 3bn Unopoly Shares Settled. Requisition Of Buckingham Palace & Windsor Castle Final
- Grads aren't getting hired — here's what we're doing about it
Emerging biotech firm debuts "Science & Shield" initiative, bridging the gap between advanced medical research and immediate humanitarian relief for the Ozarks.
BRANSON, Mo. - PrAtlas -- Metavalis, a biotechnology innovator developing a proprietary Stealth Lipid Nanoparticle (LNP) platform, is proud to announce the launch of its "Science & Shield" humanitarian initiative. To mark this milestone, the company has partnered with community organizers to host a massive winter aid event in Branson.
While Metavalis is pioneering a new generation of stealth delivery systems to tackle rare and challenging diseases, the company's leadership maintains that advanced science must be paired with immediate community care.
"Our stealth LNP technology is designed to go where other treatments can't, solving the hardest problems in medicine," said Jordan Bekemeier, Founder and CEO of Metavalis. "But while we engineer solutions for the future, we also have to solve the problems right in front of us. That is why we are deploying resources today not just in the lab, but in the parking lot, handing out supplies to neighbors who are struggling."
More on PrAtlas
Event Details:
A Dual Layer of Support The event is a coordinated effort to provide comprehensive winter protection:
About Metavalis Metavalis is a biotechnology company focused on the treatment of rare and challenging diseases through its novel Stealth LNP platform. By engineering delivery vehicles that evade immune detection, Metavalis aims to unlock new possibilities in genetic medicine. The "Science & Shield" program represents the company's commitment to protecting human life at every level from the cellular to the community.
For more information, visit the Metavalis website.
While Metavalis is pioneering a new generation of stealth delivery systems to tackle rare and challenging diseases, the company's leadership maintains that advanced science must be paired with immediate community care.
"Our stealth LNP technology is designed to go where other treatments can't, solving the hardest problems in medicine," said Jordan Bekemeier, Founder and CEO of Metavalis. "But while we engineer solutions for the future, we also have to solve the problems right in front of us. That is why we are deploying resources today not just in the lab, but in the parking lot, handing out supplies to neighbors who are struggling."
More on PrAtlas
- ASI Hosts 2026 Executive Business Summit for Global Partner Community
- Pastor Saeed Abedini Releases THE TRUTH – Volume 1, A Deeply Personal Story of Faith, Struggle, and Redemption
- New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
- Scotch Whisky Market Dislocation Creates Compelling Entry Opportunity for Long-Term Investors
- Peccioli Becomes New Orleans: In July 2026, the magic of jazz comes to Tuscany
Event Details:
- Date: Saturday, February 7, 2026
- Time: 12:00 PM – 3:00 PM CST
- Location: 993 Branson Hills Parkway, Branson, MO (Parking lot)
A Dual Layer of Support The event is a coordinated effort to provide comprehensive winter protection:
- The Davis Family will be distributing a massive supply of winter coats, hats, and heavy weather gear to protect against the cold.
- Metavalis will be distributing "Shield Kits" care packages containing non perishable food, first aid supplies (band aids, sanitizers), and hygiene essentials.
About Metavalis Metavalis is a biotechnology company focused on the treatment of rare and challenging diseases through its novel Stealth LNP platform. By engineering delivery vehicles that evade immune detection, Metavalis aims to unlock new possibilities in genetic medicine. The "Science & Shield" program represents the company's commitment to protecting human life at every level from the cellular to the community.
For more information, visit the Metavalis website.
Source: Metavalis Inc.
0 Comments
Latest on PrAtlas
- Grads aren't getting hired — here's what we're doing about it
- K2 Integrity Enhances Technology Capabilities Through Acquisition of Leviathan Security Group
- #WeAreGreekWarriors Comes to Detroit in Celebration of Women's History Month
- Energywise Solutions and Pickleball Pros Partner to Bring More Energy and Visibility to Pickleball Clubs
- Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
- The Franchise King® Releases Free Guide for Nervous Buyers
- Kanguro Insurance Taps Paylode to Launch Best-in-Class Pet and Renters Insurance Rewards Experience
- CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
- NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
- Revenue Optics Launches Talent Infrastructure Platform for SaaS Revenue Hiring and Appoints Sabz Kaur to Lead Growth
- Building a Multi-Domain Autonomous Systems Platform at the Intersection of AI, Defense and Infrastructure: VisionWave Holdings (N A S D A Q: VWAV)
- Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami
- Author Ken Mora to Celebrate New Caravaggio Book Debut with Special Event at Palazzo Venezia Naples
- Matthew Sisneros Releases Raw and Unfiltered Memoir: The Devil Lost Another One — A Powerful Story of Crime, Consequence, and Redemption
- From Life to Light: Jess L. Martinez Shares a Soulful Poetry Collection That Explores What It Means to Be Human
- Lawsuit Filed Against Boeing Over Defective Seat Switch on Boeing 787
- Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
- Danholm Collection Announces Sale of 16689 Broadwater Ave in Winter Garden, Highlighting Strong Performance in Twinwaters Community
- Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
- 46th International Symposium On Forecasting – Dates, Venue And Speakers Announced



